Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

Primary Cutaneous T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

328 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 59
Recruiting: 30
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (73)

clinicaltrialsPublishedShowing 51–62 of 62 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00769288	FAU in Treating Patients With Advanced Solid Tumors or Lymphoma	completed	Phase 1	12	National Cancer Institute (NCI)NIH	1	Jan 7, 2014	clinicaltrials
NCT01129180	Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma	completed	Phase 1	8	Pierluigi PorcuOTHER	1	Dec 3, 2013	clinicaltrials
NCT00293345